Followers | 35 |
Posts | 6308 |
Boards Moderated | 0 |
Alias Born | 02/09/2015 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, January 15, 2021 9:33:42 PM
1) the Bakovic paper re B v C has not been published in any peer review journal so far. So much for peer review, touted by the company, touted by so many here. What happened, folks? Oct 30 date( very late per Leo hype) but nothing since on the publishing front. So it was sort of a scientific, what, exactly? Good enough for a trial, not good enough for publication. Sigh.
Other data from Bakovic is NOT B, it is LL-37 for VEEV. Hey wasn't it B that was supposed to be so great for all those other viruses, per IP PRs???? Scandalous and pathetic misleading speculation by our company and our CEO, IP and Leo. Which leads us to....
2) No grant despite the hype. None. Maybe B has a role for other corona viruses, maybe not. So much grant hype, over and over, and NOTHING ever came of it. A joke played on the shareholders, who have yet to figure it out, apparently.
3)Trial did not start yet, although Leo promised q4 and said trial discussions began 9 months ago in April 2020. Any day now.
Oh yeah, the planned trial is likely to focus on those with widespread disease already, while the drug's main benefit has been reported to be stop of viral spreading.....best wishes, B, you might help, but it'll be a miracle if the human trial recapitulates the lab data. But you all know that, right?
4)People are dying by the thousands, daily, just in the US, despite standard care, and solutions are desperately needed. It is NOT AT ALL CLEAR that B is a solution despite what you may read here. Sticky this for now and and we will meet back here in 60 days and assess the COVID therapeutic world. Cross your fingers and hope that B can play a role and see you in mid March
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM
Kona Gold Beverage Inc. Signs Letter of Intent with Bemax, Inc. to Sell Kona Gold, LLC • BMXC • Aug 7, 2024 10:00 AM
Btab Ecommerce Group, Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • BBTT • Aug 7, 2024 9:00 AM
Hydromer, Inc. Announces Preliminary Unaudited Second Quarter 2024 Financial Results and Provides Business Update • HYDI • Aug 7, 2024 8:52 AM
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM